Crossmark

Treatment with carfilzomib. Should these patients be admitted to the Intensive Care Unit?

Crossref DOI link: https://doi.org/10.1016/j.medine.2017.12.003

Published Print: 2018-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Rodríguez-García, R.

Espina, M.J.

Viña, L.

Astola, I.

López-Amor, L.

Escudero, D.
License Information

Text and Data Mining valid from 2018-01-01
More Information

This article is maintained by: Elsevier

Article Title: Treatment with carfilzomib. Should these patients be admitted to the Intensive Care Unit?

Journal Title: Medicina Intensiva (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medine.2017.12.003

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medin.2017.02.004

Content Type: simple-article

Copyright: © 2017 Elsevier España, S.L.U. and SEMICYUC. All rights reserved.